Free shipping on all orders over $ 500

Pulrodemstat

Cat. No. M21313
Pulrodemstat Structure
Synonym:

CC-90011; LSD1-IN-7

Size Price Availability
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Pulrodemstat (CC-90011) is a potent, selective, reversible and orally active inhibitor of lysine-specific demethylase-1 (LSD1) with an IC50 of 0.25 nM.

Chemical Information
Molecular Weight 451.47
Formula C24H23F2N5O2
CAS Number 1821307-10-1
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Beatrice Noce, et al. Front Pharmacol. LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials

[2] Antoine Hollebecque, et al. Cancer. Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies

[3] Natalia Sacilotto, et al. ACS Pharmacol Transl Sci. Comprehensive in Vitro Characterization of the LSD1 Small Molecule Inhibitor Class in Oncology

[4] Antoine Hollebecque, et al. Clin Cancer Res. Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma

[5] Toufike Kanouni, et al. J Med Chem. Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)

Related Histone demethylase Products
INCB059872

INCB059872 is a potent, orally active, selective and irreversible inhibitor of lysine-specific demethylase 1 (LSD1) in myeloid leukemia.

KDM2A/7A-IN-1

KDM2A/7A-IN-1 is a first-in-class, selective, cell-permeable inhibitor of the histone lysine demethylase KDM2A/7A, with an IC50 value of 0.16 μM for KDM2A, 75-fold more selective than other JmjC lysine demethylases, and with no effect on methyltransferases or histone acetyltransferases. KDM2A was 75 times more selective than other JmjC lysine demethylases and had no effect on methyltransferases and histone acetyltransferases.

NCD38 TFA

NCD38 TFA is a LSD1-selective inhibitor.

LSD1-IN-26

LSD1-IN-26 is a potent LSD1 inhibitor, with an IC50 of 25.3 nM.

JMJD6-IN-1

JMJD6-IN-1 is a JMJD6 inhibitor, with an inhibition rate of 82% at 10 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Pulrodemstat, CC-90011; LSD1-IN-7 supplier, Histone demethylase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.